The program runs on Wednesday and Thursday evenings, 5 to 8 p.m., Wednesday through Dec. 11. Each of the 10 class sessions ...

Warrior Met Coal, Inc. (NYSE: HCC) ("Warrior" or the "Company") today announced results for the third quarter of 2025.

Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company with a pipeline of first-in-class1 targeted ...

Southfield School in Woods Avenue, Hatfield, has been given permission by Hertfordshire County Council to expand SEND provision ...

Recruiting never stops in college football, and Michigan State is set to host two junior college players on official visits ...

Eisai has already reached settlement agreements with two other companies seeking to market Lenvima generics in the US – Sun ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.

Dozens of pairs of shoes were laid outside Hampshire County Council’s headquarters to symbolise children who have been “let down” by ...

CHS-114, a highly selective Treg depleter, clinical program expanded to include colorectal cancer –– Q3 2025 ending cash, cash equivalents and ...